Ordering Recommendation

Detect the presence of unexpected antibodies directed against red blood cell antigens for use in pretransfusion testing, organ/tissue transplantation, evaluation of transfusion reactions, and to determine the risk for hemolytic disease of the fetus and newborn (HDFN).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Plain Red AND Lavender (K2EDTA) or Pink (K2EDTA).

Specimen Preparation

Do not freeze.
Transport 10 mL whole blood (Plain Red) AND 5 mL whole blood (EDTA). (Min: 7 mL (Plain Red) and 3 mL (EDTA))
Pediatric: Transport 1 mL whole blood (Plain Red) AND 0.5 mL whole blood (EDTA). (Min: 1 mL (Plain Red) and 0.5 mL (EDTA))

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Separator tubes.

Remarks
Stability

Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable

Methodology

Hemagglutination

Performed

Mon-Fri

Reported

1-3 days

Reference Interval

Negative

Interpretive Data



Compliance Category

FDA

Note

Panel identification will be performed on all positive specimens at an additional charge.
Positive screens are reflexed:
Female 15-45 years are reflexed to Antibody Identification, RBC (Prenatal Only) (ARUP test code 0013005)
All other Positive Screens are reflexed to Antibody ID Package (IRL) (ARUP test code 0013003)

Hotline History

N/A

CPT Codes

86850; additional CPT codes may apply

Components

Component Test Code* Component Chart Name LOINC
0010004 Antibody Detection, RBC 14575-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Antibody Screen
  • Indirect Antiglobulin
  • Indirect Coombs
Antibody Detection RBC with Reflex to ID